Ikappa-B kinase-2 inhibitor blocks inflammation in human airway smooth muscle and a rat model of asthma.

RATIONALE Nuclear factor (NF)-kappaB is a transcription factor known to regulate the expression of many inflammatory genes, including cytokines, chemokines, and adhesion molecules. NF-kappaB is held inactive in the cytoplasm, bound to I-kappaB. The removal of I-kappaB, via the actions of inhibitor of kappaB (I-kappaB) kinase-2 (IKK-2), allows NF-kappaB to enter the nucleus. OBJECTIVES To determine the impact of inhibiting IKK-2 on in vitro and in vivo models of airway inflammation. METHODS The effect of inhibiting IKK-2 was assessed in stimulated, cultured, primary human airway smooth muscle cells and an antigen-driven rat model of lung inflammation. MEASUREMENTS The release of cytokines from cultured cells and inflammatory cytokine expression and cellular burden in the lung were determined. MAIN RESULTS Two structurally distinct molecules and dominant negative technology demonstrated that inhibition of IKK-2 activity completely blocked cytokine release from cultured cells, whereas the two glucocorticoid comparators had limited impact on granulocyte colony-stimulating factor, interleukin 8, and eotaxin release. In addition, in an in vivo antigen-driven model of airway inflammation, the IKK-2 inhibitor blocked NF-kappaB nuclear translocation, which was associated with a reduction in inflammatory cytokine gene and protein expression, airway eosinophilia, and late asthmatic reaction, similar in magnitude to that obtained with budesonide. CONCLUSION This study demonstrates that inhibiting IKK-2 results in a general reduction of the inflammatory response in vitro and in vivo. Compounds of this class could have therapeutic utility in the treatment of asthma and may, in certain respects, possess a beneficial efficacy profile compared with that of a steroid.

[1]  I. Verma,et al.  Severe liver degeneration in mice lacking the IkappaB kinase 2 gene. , 1999, Science.

[2]  M. Yacoub,et al.  Effects of prostaglandin E2 and cAMP elevating drugs on GM-CSF release by cultured human airway smooth muscle cells. Relevance to asthma therapy. , 2001, American journal of respiratory cell and molecular biology.

[3]  M. Belvisi,et al.  Functional characterization and biomarker identification in the Brown Norway model of allergic airway inflammation , 2002, British journal of pharmacology.

[4]  C. Irvin,et al.  Rapid activation of nuclear factor-kappaB in airway epithelium in a murine model of allergic airway inflammation. , 2002, The American journal of pathology.

[5]  Michael Karin,et al.  NF-kappaB at the crossroads of life and death. , 2002, Nature immunology.

[6]  Sankar Ghosh,et al.  Signaling to NF-kappaB. , 2004, Genes & development.

[7]  I. Adcock,et al.  A novel transcription factor inhibitor, SP100030, inhibits cytokine gene expression, but not airway eosinophilia or hyperresponsiveness in sensitized and allergen‐exposed rat , 2001, British journal of pharmacology.

[8]  M. Yacoub,et al.  Induction of cyclo‐oxygenase‐2 by cytokines in human cultured airway smooth muscle cells: novel inflammatory role of this cell type , 1997, British journal of pharmacology.

[9]  I. Verma,et al.  IKK1-deficient mice exhibit abnormal development of skin and skeleton. , 1999, Genes & development.

[10]  P. MacAry,et al.  Expression of Th‐2 cytokines interleukin‐4 and −5 and of Th‐1 cytokine interferon‐γ in ovalbumin‐exposed sensitized Brown‐Norway rats , 1996, Immunology.

[11]  James F. Callahan,et al.  Attenuation of Murine Collagen-Induced Arthritis by a Novel, Potent, Selective Small Molecule Inhibitor of IκB Kinase 2, TPCA-1 (2-[(Aminocarbonyl)amino]-5-(4-fluorophenyl)-3-thiophenecarboxamide), Occurs via Reduction of Proinflammatory Cytokines and Antigen-Induced T Cell Proliferation , 2005, Journal of Pharmacology and Experimental Therapeutics.

[12]  Michael Karin,et al.  The Beginning of the End: IκB Kinase (IKK) and NF-κB Activation* , 1999, The Journal of Biological Chemistry.

[13]  C. Scheidereit.  Signal transduction: Docking IκB kinases , 1998, Nature.

[14]  R. Beyaert,et al.  A20 and A20-binding proteins as cellular inhibitors of nuclear factor-kappa B-dependent gene expression and apoptosis. , 2000, Biochemical pharmacology.

[15]  J. Karlsson,et al.  RPR 106541, a novel, airways‐selective glucocorticoid: effects against antigen‐induced CD4+T lymphocyte accumulation and cytokine gene expression in the Brown Norway rat lung , 1997, British journal of pharmacology.

[16]  I. Adcock,et al.  Evidence for Involvement of NF-κB in the Transcriptional Control of COX-2 Gene Expression by IL-1β ☆ , 1997 .

[17]  T. Sandström,et al.  Effects of budesonide and formoterol on NF-kappaB, adhesion molecules, and cytokines in asthma. , 2001, American journal of respiratory and critical care medicine.

[18]  I. Adcock,et al.  Activation and localization of transcription factor, nuclear factor-kappaB, in asthma. , 1998, American journal of respiratory and critical care medicine.

[19]  Michael Karin,et al.  NF-κB at the crossroads of life and death , 2002, Nature Immunology.

[20]  G. Bonizzi,et al.  Mechanisms of Persistent NF-κB Activity in the Bronchi of an Animal Model of Asthma1 , 2000, The Journal of Immunology.

[21]  X. Liu,et al.  Activation of NF-kappa B in bronchial epithelial cells from children with asthma. , 2001, Chinese medical journal.

[22]  A. Baldwin.  Series Introduction: The transcription factor NF-κB and human disease , 2001 .

[23]  T. Mosmann,et al.  Effects of Th2 cytokines on chemokine expression in the lung: IL-13 potently induces eotaxin expression by airway epithelial cells. , 1999, Journal of immunology.

[24]  S. Akira,et al.  Limb and skin abnormalities in mice lacking IKKalpha. , 1999, Science.

[25]  K. Chung,et al.  Expression and release of interleukin-8 by human airway smooth muscle cells: inhibition by Th-2 cytokines and corticosteroids. , 1998, American journal of respiratory cell and molecular biology.

[26]  C. C. Lin,et al.  Pulmonary function changes and increased Th-2 cytokine expression and nuclear factor kB activation in the lung after sensitization and allergen challenge in brown Norway rats. , 2000, Immunology letters.

[27]  P. Barnes,et al.  Quantifying proliferation of cultured human and rabbit airway smooth muscle cells in response to serum and platelet-derived growth factor. , 1992, American journal of respiratory cell and molecular biology.

[28]  A. Baldwin.  Series introduction: the transcription factor NF-kappaB and human disease. , 2001, The Journal of clinical investigation.

[29]  M. Billah,et al.  Airway eosinophils, T cells, Th2-type cytokine mRNA, and hyperreactivity in response to aerosol challenge of allergic mice with previously established pulmonary inflammation. , 1997, American journal of respiratory cell and molecular biology.

[30]  M. Yacoub,et al.  Effects of Prostaglandin E2 and cAMP Elevating Drugs on GM-CSF Release by Cultured Human Airway Smooth Muscle Cells , 2001 .

[31]  I. Adcock,et al.  NF-kappa B: a pivotal role in asthma and a new target for therapy. , 1997, Trends in pharmacological sciences.

[32]  Inder M Verma,et al.  NF-kappaB regulation in the immune system. , 2002, Nature reviews. Immunology.

[33]  T. Deerinck,et al.  Abnormal Morphogenesis But Intact IKK Activation in Mice Lacking the IKKα Subunit of IκB Kinase , 1999 .

[34]  D B Young,et al.  IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation. , 1997, Science.

[35]  Matthias Mann,et al.  IKK-1 and IKK-2: Cytokine-Activated IκB Kinases Essential for NF-κB Activation , 1997 .

[36]  A. Smahi,et al.  NEMO/IKK gamma: linking NF-kappa B to human disease. , 2001, Trends in molecular medicine.

[37]  M. Yacoub,et al.  Activation of Peroxisome Proliferator-Activated Receptors in Human Airway Smooth Muscle Cells Has a Superior Anti-inflammatory Profile to Corticosteroids: Relevance for Chronic Obstructive Pulmonary Disease Therapy 1 , 2003, The Journal of Immunology.

[38]  I. Adcock,et al.  Evidence for involvement of NF-kappaB in the transcriptional control of COX-2 gene expression by IL-1beta. , 1997, Biochemical and biophysical research communications.

[39]  David M. Rothwarf,et al.  The NF-κB Activation Pathway: A Paradigm in Information Transfer from Membrane to Nucleus , 1999, Science's STKE.

[40]  M. Belvisi,et al.  Mediator involvement in antigen‐induced bronchospasm and microvascular leakage in the airways of ovalbumin sensitized Brown Norway rats , 2001, British journal of pharmacology.

[41]  Chih‐Chung Lin,et al.  Induction of cyclooxygenase-2 expression in human tracheal smooth muscle cells by interleukin-1beta: involvement of p42/p44 and p38 mitogen-activated protein kinases and nuclear factor-kappaB. , 2004, Journal of biomedical science.

[42]  R. Homer,et al.  Essential Role of Nuclear Factor κB in the Induction of Eosinophilia in Allergic Airway Inflammation , 1998, The Journal of experimental medicine.

[43]  M. Yao,et al.  A selective IKK-2 inhibitor blocks NF-kappa B-dependent gene expression in interleukin-1 beta-stimulated synovial fibroblasts. , 2003, The Journal of biological chemistry.

[44]  Chih‐Chung Lin,et al.  Induction of Cyclooxygenase-2 Expression in Human Tracheal Smooth Muscle Cells by Interleukin-1β: Involvement of p42/p44 and p38 Mitogen-Activated Protein Kinases and Nuclear Factor-κB , 2004, Journal of Biomedical Science.

[45]  Jae-Hong Kim,et al.  Protection of Mice from Allergen-induced Asthma by Selenite , 2002, The Journal of Biological Chemistry.

[46]  M. Yao,et al.  A Selective IKK-2 Inhibitor Blocks NF-κB-dependent Gene Expression in Interleukin-1β-stimulated Synovial Fibroblasts* , 2003, Journal of Biological Chemistry.

[47]  M. Yacoub,et al.  Identification in human airways smooth muscle cells of the prostanoid receptor and signalling pathway through which PGE2 inhibits the release of GM‐CSF , 2004, British journal of pharmacology.

[48]  I. Adcock,et al.  NF-kB: a pivotal role in asthma and a new target for therapy , 1997 .

[49]  T. Deerinck,et al.  Abnormal morphogenesis but intact IKK activation in mice lacking the IKKalpha subunit of IkappaB kinase. , 1999, Science.

[50]  G. T. Sanctis,et al.  NF-kappa B/Rel transcription factors: c-Rel promotes airway hyperresponsiveness and allergic pulmonary inflammation. , 1999, Journal of immunology.

[51]  M. Yacoub,et al.  Prostanoid receptor expression by human airway smooth muscle cells and regulation of the secretion of granulocyte colony-stimulating factor. , 2005, American journal of physiology. Lung cellular and molecular physiology.

[52]  J. Renner,et al.  Efficacy of alendronate in adults with cystic fibrosis with low bone density. , 2004, American journal of respiratory and critical care medicine.

[53]  Inder M. Verma,et al.  Severe Liver Degeneration in Mice Lacking the IκB Kinase 2 Gene , 1999 .

[54]  A. Smahi,et al.  NEMO/IKK?: linking NF-?B to human disease , 2001 .